Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies - Top-Institutions - MDSpire

Sjögren's Syndrome: The Role of B Cells in Autoimmunity, Lymphoma Development, and Emerging B Cell-Directed Treatments

  • By

  • Rachael A. Gordon

  • Sara S. McCoy

  • July 1, 2026

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    The Johns Hopkins Hospital – Division of Rheumatology; Jerome L. Greene Sjögren’s Disease Center
    The Johns Hopkins Hospital – Division of Rheumatology; Jerome L. Greene Sjögren’s Disease Center

    Baltimore, Maryland

    Key Differentiators

    • Rheumatology

  • #2

    Mayo Clinic – Department of Rheumatology
    Mayo Clinic – Department of Rheumatology

    Rochester, Minnesota

    Key Differentiators

    • Rheumatology

  • #3

    Toronto Western Hospital
    Toronto Western Hospital

    Toronto, Ontario

    Key Differentiators

    • Rheumatology

  • #4

    Hannover Medical School
    Hannover Medical School

    Hannover, Lower Saxony

    Key Differentiators

    • Rheumatology

  • #5

    Sjögren's Syndrome Foundation
    Sjögren's Syndrome Foundation

    Not specified, Not specified

    Key Differentiators

    • Rheumatology

Original Source(s)

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

  • by Rachael A. Gordon, Sara S. McCoy

  • July 1, 2026

Related Content

Rheumatoid Arthritis and Coronary Artery Calcium Progression: A Case Cohort Analysis From ELSA-Brasil

Synovial Fluid Cell Profiling Identifies Distinct Inflammatory Phenotypes in Late-Onset Rheumatoid Arthritis and Polymyalgia Rheumatica

Editorial: Characterising the functional heterogeneity of synovial macrophages